About Kowa Pharma
Kowa Pharma is a company based in Montgomery (United States) founded in 2008. It operates as a B2B. The company has 342 employees. Kowa Pharma operates in a competitive market with competitors including Cellino, Tenaya Therapeutics, MyoKardia, Eiger BioPharmaceuticals and Capricor Therapeutics, among others.
- Headquarter Montgomery, United States
- Employees 342
- SectorsHealthcare
- Phone•••• ••••
- Website kowapharma.com
- Social LinkedIn
- Employee Count342
Competitors of Kowa Pharma
Kowa Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellino, Tenaya Therapeutics, MyoKardia, Eiger BioPharmaceuticals and Capricor Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cellinobio.com | 2017 | Cambridge, United States | $125M | 63 | Developer of autologous cell therapies | |
| tenayatherapeutics.com | 2016 | San Francisco, United States | $142M | 140 | Regenerative and gene therapeutics for heart failure are developed. | |
| myokardia.com | 2012 | San Francisco, United States | $98M | 224 | Specialized drugs are developed for genetic heart diseases. | |
| eigerbio.com | 2000 | San Carlos, United States | $8.9M | 56 | Developer of antiviral agents against targets in the treatment of hepatitis | |
| capricor.com | 2005 | Los Angeles, United States | – | 62 | Regenerative medicine for cardiovascular disorders is developed using cell-based platforms. | |
| arrakistx.com | 2015 | Waltham, United States | $113M | 91 | Provider of tools for the analysis of RNA structures | |
| esperion.com | 1998 | Ann Arbor, United States | $129.7M | 240 | Therapies for lowering low-density lipoprotein cholesterol levels are developed. | |
| cardurion.com | 2017 | Boston, United States | $270M | – | Therapeutics for heart and cardiovascular diseases are developed. |
Detailed competitors of Kowa Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Kowa Pharma
Websites that share an audience with Kowa Pharma (kowapharma.com).
Websites whose visitors overlap most with Kowa Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| otsuka.com | 76% | 47.2K | #682,452 | View details |
Latest news on Kowa Pharma
Complete news archive for Kowa Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Kowa Pharma
10 companies that operate in the same segment as Kowa Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kowa Pharma
Kowa Pharma was founded in 2008.
Kowa Pharma is headquartered in Montgomery, United States. It is registered at Montgomery, Alabama, United States.
Kowa Pharma has 342 employees.
Kowa Pharma, based in Montgomery, focuses on providing healthcare solutions, producing pharmaceutical products, therapeutics, and cardiometabolic. Specializes in developing therapeutics for cardiometabolic conditions. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Kowa Pharma's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.